Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arax Hovhannesyan
Observed names:
A. Hovhannesyan,
Araksya Hovhannesyan,
Arax Hovhanessyan
Institutions:
World Health Organization Regional Office for Europe,
World Health Organization - Denmark
Observed institutions:
World Health Organization Regional Office for Europe,
World Health Organization - Denmark,
World Health Organization
ORCID:
0000-0002-7904-9071
Observed ORCID:
0000-0002-7904-9071
OpenAlex ID:
A5070152168
Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data
2019
·
Andrei Dadu
, Arax Hovhannesyan
, et al.
·
The Lancet Infectious Diseases
·
54
Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey
2018
·
E. Pavlenko
, A. Barbova
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
46
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
2024
·
Oleksandr Korotych
, Jay Achar
, et al.
·
The Lancet Infectious Diseases
·
42
Behavior change communication model enhancing parental practices for improved early childhood growth and development outcomes in rural Armenia – A quasi-experimental study
2019
·
Alfonso Rosales
, Viktoria Sargsyan
, et al.
·
Preventive Medicine Reports
·
28
Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
2021
·
Aleksandr Trubnikov
, Arax Hovhannesyan
, et al.
·
International Journal of Environmental Research and Public Health
·
25
PDF
Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020
2021
·
Teona Avaliani
, Yuliia Sereda
, et al.
·
Monaldi Archives for Chest Disease
·
21
PDF
Social determinants and risk factors for tuberculosis in national surveillance systems in Europe
2015
·
P. de Colombani
, A. Hovhannesyan
, et al.
·
Public Health Action
·
16
Tuberculosis Notification Trends and Treatment Outcomes in Penitentiary and Civilian Health Care Sectors in the WHO European Region
2021
·
Andrei Dadu
, Ana Ciobanu
, et al.
·
International Journal of Environmental Research and Public Health
·
15
PDF
Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017
2021
·
Sherali Massavirov
, Kristina Akopyan
, et al.
·
International Journal of Environmental Research and Public Health
·
15
PDF
Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan
2021
·
Dilbar Sadirova
, Ruzanna Grigoryan
, et al.
·
International Journal of Environmental Research and Public Health
·
12
PDF
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan
2021
·
Jamshid Gadoev
, Damin Asadov
, et al.
·
International Journal of Environmental Research and Public Health
·
10
PDF
Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan
2021
·
Anvar Riskiyev
, Ana Ciobanu
, et al.
·
International Journal of Environmental Research and Public Health
·
9
PDF
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018
2021
·
Mariana Buziashvili
, Hayk Davtyan
, et al.
·
Monaldi Archives for Chest Disease
·
7
PDF
Time to sputum conversion in multidrug-resistant tuberculosis patients in Armenia: retrospective cohort study
2012
·
Arax Hovhannesyan
, Elizabeth Breeze
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
7
TB prevention activities in the WHO European Region
2024
·
A. Matteelli
, Z. Mkrtchyan
, et al.
·
IJTLD OPEN
·
6
Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study
2022
·
Nazgul Soltobekova
, Turatbek Kozukeev
, et al.
·
PLoS ONE
·
6
PDF
Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan
2021
·
Fazlkhan Abdugapparov
, Ruzanna Grigoryan
, et al.
·
International Journal of Environmental Research and Public Health
·
5
PDF
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
2024
·
G.B. Migliori
, O. Korotych
, et al.
·
IJTLD OPEN
·
3
Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023
2025
·
Irina Felker
, Alexandra Solovyeva
, et al.
·
Eurosurveillance
·
1
PDF
Frequency of serious adverse events on therapy with modified fully oral shorter treatment regimens (mSTR) for MDR/RR-TB
2023
·
Elmira Gurbanova
, Natalia Yatskevich
, et al.
·
European Respiratory Journal
Tuberculosis in Women
2021
·
Paul P. Nunn
, Araksya Hovhannesyan
, et al.
·
Springer eBooks
'Go Baby Go'; Community-Based Integrated Early Childhood and Maternal Child Health Model Improving Early Childhood Stimulation, Care Practices and Developmental Outcomes in Armenia: A Quasi-Experimental Study
2017
·
Viktorya Sargsyan
, Arax Hovhannesyan
, et al.
·
World Academy of Science, Engineering and Technology, International Journal of Educational and Pedagogical Sciences
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe
2016
·
Dennis Falzon
, Andrei Dadu
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
23
Citation count:
328
H-index:
10
I10-index:
11
Year
Topic
Type